RDY

Dr Reddys Laboratories Ltd
53.09
-0.74 (-1.37%)
Company Name Stock Ticker Symbol Market Type
Dr Reddys Laboratories Ltd RDY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.74 -1.37% 53.09 20:00:00
Open Price Low Price High Price Close Price Prev Close
53.40 52.85 53.54 53.09 53.83
more quote information »

Recent News

Date Time Source Heading
1/27/202309:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/27/202307:03BWDr. Reddy's Laboratories announces the launch of..
1/27/202306:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/26/202311:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/25/202314:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/25/202314:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/25/202313:39EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/20/202317:56DJNADRs End Higher; ABB, Dr. Reddy's Trade Actively
1/20/202306:30BWDr. Reddy’s successfully completes full set of clinical..
1/20/202306:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/13/202307:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/27/202208:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/27/202206:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/19/202208:00BWDr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC,..
12/16/202206:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/07/202206:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/22/202214:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202213:28EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/31/202207:44EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/30/202221:20TRMNAnalysts Offer Insights on Healthcare Companies: Edwards..
10/13/202207:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/12/202205:49BWWeltwirtschaftsforum nimmt Werk von Dr. Reddy’s in Hyderabad..
10/11/202207:57BWWorld Economic Forum Recognises Dr. Reddy’s Hyderabad..
9/29/202210:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/27/202206:39EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/23/202207:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/20/202213:40EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/19/202206:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/12/202206:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/08/202206:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/07/202213:28BWDr. Reddy's Laboratories Announces the Launch of..
9/07/202206:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/08/202206:23EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/03/202209:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/01/202214:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/01/202212:46EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/29/202213:24BWDr. Reddy's Laboratories enters into a licensing agreement..
7/29/202206:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/27/202208:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/27/202203:26BWDr. Reddy's Laboratories announces the launch of Bortezomib..
7/22/202213:46EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/22/202206:17BWDr. Reddy’s Announces the First-to-Market Launch of..
7/14/202206:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/12/202206:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/08/202213:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/08/202211:48BWDr. Reddy's Laboratories Announces the Launch of..
7/07/202212:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/07/202207:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/05/202222:53BWオーリジーン・ディスカバリー・テクノロジーズ・リミテッドがEQRxと創薬・開発・商業化で提携した発表
7/05/202214:46BWAurigene Discovery Technologies Limited kündigt..